Ocba, Fe G.
HRN: 21-96-67 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2022
CEFUROXIME 500MG (TAB)
11/10/2022
11/17/2022
PO
500mg
BID
2nd Degree RMLE
Waiting Final Action